Abeona Therapeutics Inc (ABEO)
4.43
+0.03
(+0.68%)
USD |
NASDAQ |
May 20, 15:34
Abeona Therapeutics Cash from Operations (Quarterly): -14.54M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.54M |
| December 31, 2023 | -9.235M |
| September 30, 2023 | -5.746M |
| June 30, 2023 | -10.28M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -13.99M |
| September 30, 2022 | -6.791M |
| June 30, 2022 | -9.013M |
| March 31, 2022 | -13.69M |
| December 31, 2021 | -30.26M |
| September 30, 2021 | -10.33M |
| June 30, 2021 | -11.49M |
| March 31, 2021 | -13.58M |
| December 31, 2020 | -1.61M |
| September 30, 2020 | -10.70M |
| June 30, 2020 | -9.475M |
| March 31, 2020 | -13.23M |
| December 31, 2019 | -14.25M |
| September 30, 2019 | -18.25M |
| June 30, 2019 | -15.24M |
| March 31, 2019 | -15.08M |
| December 31, 2018 | -16.97M |
| September 30, 2018 | -9.04M |
| June 30, 2018 | -9.022M |
| March 31, 2018 | -4.082M |
| Date | Value |
|---|---|
| December 31, 2017 | -5.046M |
| September 30, 2017 | -6.77M |
| June 30, 2017 | -4.982M |
| March 31, 2017 | -5.857M |
| December 31, 2016 | -3.393M |
| September 30, 2016 | -3.989M |
| June 30, 2016 | -3.116M |
| March 31, 2016 | -2.516M |
| December 31, 2015 | -2.877M |
| September 30, 2015 | -2.512M |
| June 30, 2015 | -1.871M |
| March 31, 2015 | -3.163M |
| December 31, 2014 | -1.102M |
| September 30, 2014 | -0.14M |
| June 30, 2014 | -0.244M |
| March 31, 2014 | -0.125M |
| December 31, 2013 | -0.474M |
| September 30, 2013 | -0.916M |
| June 30, 2013 | 1.737M |
| March 31, 2013 | -0.346M |
| December 31, 2012 | -1.616M |
| September 30, 2012 | -0.482M |
| June 30, 2012 | -0.775M |
| March 31, 2012 | -1.082M |
| December 31, 2011 | -1.964M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.26M
Minimum
Dec 2021
-1.61M
Maximum
Dec 2020
-12.17M
Average
-11.62M
Median
Cash from Operations (Quarterly) Benchmarks
| T2 Biosystems Inc | -11.68M |
| INVO Bioscience Inc | -0.7149M |
| Perspective Therapeutics Inc | 13.85M |
| Electromed Inc | 1.351M |
| Xtant Medical Holdings Inc | -5.755M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -7.817M |
| Cash from Financing (Quarterly) | 25.44M |
| Free Cash Flow | -40.64M |
| Free Cash Flow Per Share (Quarterly) | -0.5588 |
| Free Cash Flow Yield | -38.29% |